Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Gynecologic 3Lymphoid 2Head & Neck 2Genitourinary 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Endocrine 1CNS 1Breast 1

Conditions

Neuroblastoma 1Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 78Magnetic Resonance Spectroscopy 69Specimen Handling 45Radiotherapy 42Bevacizumab 28Radiosurgery 27Cyclophosphamide 27pembrolizumab 20Radiation 20Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 14Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11Surgical Procedures, Operative 9trametinib 8dinutuximab 8abemaciclib 8Ipilimumab 8Fluorodeoxyglucose F18 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Data Collection × CNS × Clear all
NCT04253015 2024-02-07

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

RECORDATI GROUP

Recruiting
125 enrolled
CNS

Brain Neoplasms, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡